Status:
UNKNOWN
PORH and Response to Cold in Raynaud's Phenomenon.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Raynaud Disease
Hyperemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of the study is to determine if implication of epoxy-eicosatriénoïc acids (EETs) and NO during cutaneous post-occlusive hyperemia differs between patients with Raynaud phenomena and...
Detailed Description
The main objective of the study is to determine if implication of epoxy-eicosatriénoïques acids (EETs) and NO during cutaneous post-occlusive hyperemia differs between patients with Raynaud phenomena ...
Eligibility Criteria
Inclusion
- Neither raynaud's phenomenon or chronic disease for healthy volunteers
- Raynaud's phenomenon without connective tissue disease for patients in the group "Raynaud"
Exclusion
- History of axillary dissection , trauma or surgery
- History of thromboembolic disease or thrombophilia
- Minor or law-protected major
- Exclusion period in another study
- No affiliation to medicare
- Pregnant, parturient or breasting woman
- Concomitant serious disease: progressive cancer, liver failure, history of myocardial infarction less than 5 years, angor
- Smoking in the 6 last months
- Person deprived of liberty by a legal or administrative decision, person under legal protection
- Maximal annual indemnification reached.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02183779
Start Date
June 1 2014
End Date
June 1 2017
Last Update
December 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'investigation clinique CIC1406
Grenoble Cedex9, France, 38043